02273 GUSHENGTANG
- 47.350
- +0.150+0.32%
GUSHENGTANG News
April 26 Repurchase Collection | Hang Seng Bank, Swire Group A and others bought back one after another. Of these, Hang Seng Bank spent HK$61.74,141 million
According to HKEx's April 29 disclosure documents, $Hang Seng Bank (00011.HK) $ and $Swire Group A (00019.HK) $ repurchased shares. ① $Hang Seng Bank (00011.HK) $ repurchased 600,000 common shares on April 26, involving an amount of HK$6,1714,400. The repurchase price per share ranged from HK$103.3 to HK$102.2. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) was 6.314 million shares, accounting for 0.33% of the number of shares issued when the ordinary resolution was passed. ② $too
Gushengtang (2273.HK): Maintaining rapid business growth in 1Q24
Goseido updated its 1Q24 business data. The number of patients treated in 1Q24 was about 1.07 million, an increase of about 42.1% over the previous year. Among these, newly established stores were 1Q from April 1, 23 to March 31, 24
Gushengtang Logs 42% Boost in Q1 Customer Visits
Gushengtang Holdings (HKG:2273) recorded around 1.1 million customer visits during the three months ended March 31, up 42.1% from the year-ago figure of 756,000 visits, a Thursday filing on the Hong K
On April 26, Gushengtang (02273.HK) spent HK$1.33 million to repurchase 29,600 shares
Gelonghui, April 26 | Gushengtang (02273.HK) announced that it spent HK$1.33 million to repurchase 29,600 shares on April 26.
The total number of visits to Gushengtang (02273.HK) customers in the first quarter was about 1.074,000, an increase of about 42.1% year-on-year
Gelonghui, April 25 | Gushengtang (02273.HK) announced that the total number of customer visits in the three months ended March 31, 2024 was about 1.074,000, an increase of about 42.1% over the same period in 2023 (about 756,000 customer visits). In the three months ended March 31, 2024, the total number of customer visits to the company's newly established medical institutions was about 74,000, accounting for 9.8% of the 42.1% increase in the number of patients treated above.
固生堂：2023年度報告
Goseido (02273.HK) cancelled 1.54 million shares on April 19
Gelonghui, April 19, 丨 Gushengtang (02273.HK) announced that on April 19, 2024, the company cancelled 1.54 million repurchased shares.
Gushengtang (02273.HK): The countercyclical advantage of leading traditional Chinese medicine chain diagnosis and treatment highlights the acceleration of expansion
Key investment points: The countercyclical nature of leading TCM chain diagnosis and treatment is prominent. National expansion is expected to accelerate, driving performance beyond expectations. Market expectations: Endogenous growth is relatively stable, and rapid large-scale nationwide expansion is difficult. 1) Refer to historical acquisition data
Repurchase Collection on April 16 | HSBC Holdings, Changshi Group, etc. bought back one after another, of which HSBC Holdings spent HK$206 million
According to documents disclosed by the Hong Kong Stock Exchange on April 17, $HSBC Holdings (00005.HK) $, $Changshi Group (01113.HK) $, etc. repurchased shares. ① $HSBC Holdings (00005.HK) $ repurchased 3.2412 million common shares on April 15, involving an amount of HK$206 million. The repurchase price per share ranged from HK$63.85 to HK$63.1. ② $Changshi Group (01113.HK) $ repurchased 2,434,500 common shares on April 16, involving an amount of HK$76.3271 million, with a repurchase price of HK$31.4 per share
On April 16, Gushengtang (02273.HK) spent HK$5.2471 million to buy back 130,000 shares
Gushengtang (02273.HK) announced that on April 16, 2024, the company spent HK$5.2471 million to repurchase 130,000 shares at a repurchase price of HK$40-41 per share.
Repurchase Collection on April 15 | HSBC Holdings, Hang Seng Bank, etc. bought back one after another, of which HSBC Holdings spent HK$263 million
According to HKEx's April 16 disclosure documents, $HSBC Holdings (00005.HK) $ and $Hang Seng Bank (00011.HK) $ repurchased shares. ① $HSBC Holdings (00005.HK) $ repurchased 4.147,200 common shares on April 12, involving an amount of HK$263 million. The repurchase price per share ranged from HK$63.85 to HK$63.05. ② $Hang Seng Bank (00011.HK) $ repurchased 5992 thousand common shares on April 15, involving an amount of HK$58.728 million, with a repurchase price of HK$99.3 per share
On April 15, Gushengtang (02273.HK) spent HK$5.74 million to buy back 140,000 shares
On April 15, Gelonghui (02273.HK) announced that on April 15, it spent HK$5.74 million to repurchase 140,000 shares at a price of HK$40.6-41.2 per share.
Repurchase Collection on April 12 | Tencent Holdings, HSBC Holdings, etc. have repurchased, of which Tencent Holdings spent HK$1 billion
According to documents disclosed by the Hong Kong Stock Exchange on April 15, $Tencent Holdings (00700.HK) $ and $HSBC Holdings (00005.HK) $ repurchased shares. ① $Tencent Holdings (00700.HK) $ repurchased 3.2 million common shares on April 12, involving an amount of HK$1 billion. The repurchase price per share ranged from HK$317.4 to HK$309.4. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 212 million shares, accounting for 2.211% of the number of shares issued when the ordinary resolution was passed. ② $HSBC Holdings (0000
Gushengtang (2273.HK): Performance is in line with expectations, continuous verification of Gusheng Medical's customer acquisition capability
Guide to this report: Performance is in line with expectations, and profitability is improving steadily. As medical consortium cooperation continues to advance, the number of doctors is steadily increasing, and it is expected that steady and rapid growth will continue and maintain an increase rating. Summary: The performance was in line with expectations, and the rating for increasing holdings was maintained. incorporation
On April 12, Gushengtang (02273.HK) spent HK$3.357 million to repurchase 80,000 shares
On April 12, Gelonghui (02273.HK) announced that on April 12, it spent HK$3.357 million to repurchase 80,000 shares at a price of HK$41.75-42.1 per share.
China Post Securities: Endogenous growth is steady, and the Hong Kong stock healthcare services sector's valuation is highly attractive
Judging from the overall performance of medical service targets in Hong Kong stocks, with the exception of ICL's high revenue base in the early COVID-19 period, where dental revenue was affected by dental implant collection, most of the revenue from other medical service targets increased relatively well.
Multiple arrows in unison! Pharmaceutical innovation support policies are coming
Recently, many places, including Beijing, Guangzhou, and Zhuhai, have successively issued relevant policies (draft for comments) to support the high-quality development of the biomedical industry or innovative pharmaceutical devices. The intensive introduction of support policies and the tight schedule have attracted great attention from the industry.
Repurchase Collection on April 5 | Tencent Holdings, Changshi Group, etc. bought back one after another, of which Tencent Holdings spent HK$1.03 billion
According to documents disclosed by the Hong Kong Stock Exchange on April 8, $Tencent Holdings (00700.HK) $ and $Changshi Group (01113.HK) $ repurchased shares. ① $Tencent Holdings (00700.HK) $ repurchased 3.25 million common shares on April 5, involving an amount of HK$1,003 billion. The repurchase price for each share ranged from HK$311.2 to HK$304.4. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 196 million shares, accounting for 2.043% of the number of shares issued when the ordinary resolution was passed. ② $Changshi Group (011
Express News | Guojin Securities: Focus on opportunities such as in vitro diagnostic collection clean-up and proprietary Chinese medicine collection
Gushengtang (02273.HK) spent HK$2.98 million to buy back 70,000 shares on April 5
Gelonghui, April 5 | Gushengtang (02273.HK) announced that on April 5, it spent HK$2.98 million to repurchase 70,000 shares at a price of HK$42.2-43.2 per share.
Analysis
Price Target
No Data
